News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
Top Breaking News
Exelixis, Inc. (EXEL) Chops 70 Percent Of Workforce After Prostate Drug Cabozantinib Fails Pivotal Study     9/2/2014
Novo Nordisk A/S (NVO) Drops Inflammatory Disorder Business; 400 Staffers Impacted     9/2/2014
Novartis AG (NVS)'s New Heart Drug Cuts Cardiovascular Death Risk By 20 Percent; "Most Exciting Ever" Med Points To Huge Sales     9/2/2014
Early Phase 3 Data Suggest Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN) Drug May Halve Heart Risk     9/2/2014
Belgium Biotech ThromboGenics NV (TBGNF) Cuts Around A Fifth Of Employees     9/2/2014
Resverlogix Corporation (RVX.TO)'s RVX-208 Leads To A 77 Percent Relative Risk Reduction Of Major Heart Events     9/2/2014
San Diego's ACADIA Pharmaceuticals, Inc. (ACAD) Wins FDA Breakthrough Therapy Designation For NUPLAZID™     9/2/2014
Bristol-Myers Squibb Company (BMY) Gives Back Rights To Alder Biopharmaceuticals Inc.'s Promising Arthritis Drug Clazakizumab     9/2/2014
Bayer HealthCare (BAY) Starts Its Own Accelerator     9/2/2014
Shareholders Revolt Over GlaxoSmithKline (GSK)'s Plans To Shake Up Board; Investors Call For Speedy Departure Of Chairman Gent     9/2/2014
Baxter International, Inc. (BAX)'s Hunt For Space In Cambridge Triggers A Counter Effort In Illinois     9/2/2014
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden     9/2/2014
Amgen (AMGN) Submits Marketing Authorization Application For Cholesterol-Lowering Medication Evolocumab     9/2/2014
Amgen (AMGN) Submits Marketing Authorization Application For Talimogene Laherparepvec     9/2/2014
Clearside Biomedical Snags $16 Million Series B Financing     9/2/2014

Featured Stories
"Back To Normal" For AstraZeneca PLC (AZN) CEO, Despite Pfizer Inc. (PFE) Rumors     9/2/2014
Wine Only Protects The Heart When You Exercise, Palacky University Study     9/2/2014
Drinking Tea, Not Coffee, Could Help You Live Longer, European Society of Cardiology Reveals     9/2/2014
How Plants In The Office Make Workers More Productive, University of Exeter Study     9/2/2014
Dieting? Low-Carb Trumps Low-Fat For Weight Loss, Heart Health, Tulane University Study     9/2/2014
Energy Drinks Cause Heart Problems, European Society of Cardiology Reveals     9/2/2014
Coffee And Nap Can Increase Alertness, Loughborough University Study     9/2/2014
Boy Born Without A Brain Dies At Age 12     9/2/2014
Chinese Farmer Whose Head Was Crushed Will Be Fitted With 3D-Printed Skull, Xijing Hospital Reveals     9/2/2014
Short Men Make Better Boyfriends And Husbands, New York University Study     8/29/2014
Certain Toothbrushes Hold 3,000 Times More Germs, University of Texas Health Science Center Researchers Reveal     8/29/2014
Angry Face May Make You Appear Stronger, University of California, Santa Barbara Study     8/29/2014
Household Germs Follow You Wherever You Go, Argonne National Laboratory And University of Chicago Study     8/29/2014
Why Synthetic Marijuana Is More Toxic To The Brain Than Pot     8/29/2014
Prenatal Antidepressants May Be Linked To Autism, Massachusetts General Hospital Study     8/29/2014

More News
Allergan Inc. (AGN) Announces OZURDEX® (Dexamethasone 700 Mcg Intravitreal Implant In Applicator) Now Approved In The European Union For The Treatment Of Diabetic Macular Edema     9/2/2014
New Indication For VIMPAT® (Lacosamide): UCB Group (UCBJF.PK)'s Anti-Epileptic Drug Approved By FDA As Monotherapy In The Treatment Of Patients With Partial-Onset Seizures     9/2/2014
GE Healthcare Announces European Union Approval Of VIZAMYL™ (Flutemetamol (18F) Solution For Injection) For PET Imaging Of Beta Amyloid Plaque In Suspected Alzheimer’s Disease     9/2/2014
Salix Pharmaceuticals, Ltd. (SLXP) Submits Response To XIFAXAN® 550mg Complete Response Letter Regarding Repeat Treatment For Irritable Bowel Syndrome With Diarrhea     9/2/2014
Ipsen (IPN.PA) Announces Acceptance Of Filings For Somatuline® In The Treatment Of GEP-NET1s In The U.S. With Priority Review And In Europe     9/2/2014
Actavis (ACT) Announces FDA Acceptance For Filing Of NDA For Eluxadoline     9/2/2014
Hatchtech Announces Successful Phase 3 Study Results For Xeglyze™ Lotion     9/2/2014
Birken Announces Positive Results Of Phase III Trials With Oleogel-S10 For Accelerated Wound Healing In Patients With Partial Thickness Wounds     9/2/2014
Macrocure (MCUR) Completes Enrollment In Pivotal Phase 3 Clinical Trial Of Curexcell In Diabetic Foot Ulcers     9/2/2014
Sophiris Bio Inc. (SPHS) Reports Completion Of Enrollment In The "PLUS-1" Phase 3 Trial Of PRX302 For Benign Prostatic Hyperplasia     9/2/2014
Conatus Pharmaceuticals Inc. Initiates Phase 2 Trial In Patients With Liver Cirrhosis And Separate Open Label Phase 2 Trial In Cirrhosis Patients With Portal Hypertension     9/2/2014
Alcobra (ADHD) Announces Enrollment Of First Patient In Phase 2b Clinical Trial Of MDX In Adolescents With ADHD     9/2/2014
Cellular Biomedicine Group (CBMG) Launches Clinical Research Study For Cartilage Defect Stem Cell Therapy     9/2/2014
Nuvilex (NVLX) Submits Application For Orphan Drug Designation To The European Medicines Agency For Its Cell-In-A-Box® Treatment For Pancreatic Cancer     9/2/2014
Promedior Receives U.S. Orphan Drug Designation For PRM-151 For The Treatment Of Myelofibrosis     9/2/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Initiates Phase 1(B) Safety And Tolerance Study For CPP-115     9/2/2014
Capstone Therapeutics (CAPS) Announces Phase 1a Results For AEM-28 Showing Safety And Biomarker Efficacy Signals     9/2/2014
Vifor Pharma Release: CONFIRM-HF Study Demonstrates That Injectafer® (Ferinject®) Improves Exercise Capacity In Patients With Chronic Heart Failure     9/2/2014
Zogenix, Inc. (ZGNX) Release: Zohydro® ER Demonstrates Sustained 12-Hour Pain Relief     9/2/2014
Boehringer Ingelheim Corporation Release: European Society of Cardiology Congress 2014 Hot Line Session: Favourable Effect Of Pradaxa® On Kidney Function Over Time Compared To Warfarin     9/2/2014
Imperial College London To Present First Public HBV Data From CN Bio Innovations In Vitro Liver Model     9/2/2014
Galleon Pharmaceuticals, Inc. Announces Publication Of Proof-Of-Concept Clinical Studies For GAL-021, Projected Use For The Emerging Perioperative Sleep Apnea Epidemic     9/2/2014
Promedior Receives U.S. Orphan Drug Designation For PRM-151 For Fhe Treatment Of Myelofibrosis     9/2/2014
Agendia BV Announces Study Showing Molecular Subtyping Can Improve Breast Cancer Treatment     9/2/2014
BioLegend Acquires The Antibody Products Business Unit From Covance Inc. (CVD)     9/2/2014
Ablynx (ABLYF) Signs Exclusive License Agreement With Eddingpharm (Cayman) Inc. To Develop And Commercialise Its Anti-Tnfa Nanobody In Greater China     9/2/2014
Amarillo Biosciences (AMAR) Initiates CLIA Development Of Alzheimer's Blood Diagnostic Lympro Test® At ICON Central Laboratories     9/2/2014
Chimerix, Inc. (CMRX) And Biomedical Advanced Research and Development Authority (BARDA) Announce Continued Partnership In The Development Of Brincidofovir For Smallpox     9/2/2014
CleveXel Pharma Partners With Guilin Pharmaceutical To Develop Two New Anti-Malarial Products     9/2/2014
Advanced Biological Laboratories SA (ABL) And Mayo Medical Laboratories Announce Collaboration And Licensing Agreements     9/2/2014
EMD Group (EMD Millipore Headquarters) And Massachusetts General Hospital Collaborate To Better Understand Systemic Lupus Erythematosus And Lupus Nephritis     9/2/2014
Lundbeck Inc. (LUN.CO) Announces Availability Of NORTHERA™ (droxidopa) Capsules In The U.S. For Symptomatic Neurogenic Orthostatic Hypotension     9/2/2014
United States Patent & Trademark Office Issues Three New Standard Essential Patents To Spherix (SPEX)     9/2/2014
Marinus Pharmaceuticals (MRNS) Announces Exercise Of Over-Allotment Option In Public Offering Of Common Stock     9/2/2014
Agile Therapeutics, Inc. To Ring The NASDAQ Stock Market Closing Bell     9/2/2014
Aurinia (ISA.TO) To Begin Trading On The NASDAQ Global Market     9/2/2014
Creative BioMart Session---Summary Of August Promotion     9/2/2014
TAP Biosystems Release; Major Pharma Chooses CompacT SelecT Automated Cell Culture SystemTo Generate Consistent, High Quality Cell Plates For Transport Assays     9/2/2014
Cellectis (ALCLS): Genome Engineering & CART Cells: At The Forefront Of Immuno-Oncology     9/2/2014
Lorus Therapeutics Inc. (LRP) Implements Name Change To Aptose Biosciences     9/2/2014
DS Healthcare Group To Open Its First DS Laboratories Hair Loss Clinic Offering Patients Unique Personalized Therapies For Hair Loss     9/2/2014
Source BioScience Launches Intelligent GenomeCUBE Search Engine     9/2/2014
ERYtech Pharma Business Update And Financial Results For The First Half Of 2014     9/2/2014
uniQure Announces Results For The Second Quarter And First Half Of 2014 And Provides Update On Gene Therapy Programs     9/2/2014
TiGenix Appoints Chief Medical Officer And Vice President Medical Affairs And New Product Commercialisation     9/2/2014
Tokai Pharmaceuticals Appoints Lee Kalowski As Chief Financial Officer     9/2/2014
Mast Therapeutics (MSTX) Announces Management Change     9/2/2014
Sierk Pötting To Be The New CFO (Chief Financial Officer) Of BioNTech Group     9/2/2014
Aldeyra Therapeutics (ALDX) Expands Drug Development Team In Advance Of NS2 Clinical Trials     9/2/2014
Distinguished Scientists Join Advanced Cell Technology’s New Scientific Advisory Board     9/2/2014
MediciNova, Inc. To Present Data On MN-001 (Tipelukast) For The Treatment Of Idiopathic Pulmonary Fibrosis (IPF) During The 18th International Colloquium On Lung And Airway Fibrosis (ICLAF)     9/2/2014
Vectura Group plc (VEC.L) Release: Presentations At ERS     9/2/2014
Dipexium Pharmaceuticals (DPRX) Announces Presentation At Rodman & Renshaw 16th Annual Global Investment Conference     9/2/2014
Imperial College London To Present First Public HBV Data From CN Biosciences (CNBI) In Vitro Liver Model     9/2/2014
NephroGenex (NRX) To Participate In Four Healthcare Conferences In September     9/2/2014
Merck & Co., Inc. (MRK) To Present New Data In Five Tumor Types From Studies Evaluating Pembrolizumab, The Company’s Investigational Anti-PD-1 Antibody, At ESMO 2014     9/2/2014
Portola Pharmaceuticals, Inc. To Present At The 2014 Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Versartis, Inc. (VSAR) To Present At The Morgan Stanley (MST) 2014 Global Healthcare Conference     9/2/2014
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
XenoPort, Inc. (XNPT) To Present At The Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Bristol-Myers Squibb Company (BMY) To Take Part In Morgan Stanley (MST) Global Health Care Conference     9/2/2014
Seattle Genetics, Inc. (SGEN) To Present At Morgan Stanley (MST) Healthcare Conference     9/2/2014
Thermo Fisher Scientific (TMO) To Present At The Morgan Stanley (MST) Global Healthcare Conference On September 9, 2014     9/2/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) To Present At 16th Rodman & Renshaw Annual Global Investment Conference     9/2/2014
Celator Pharmaceuticals, Inc. To Present At Rodman & Renshaw 16th Annual Global Investment Conference     9/2/2014
BioLineRx Ltd. To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York     9/2/2014
Biocryst Pharmaceuticals (BCRX) To Present Peramivir Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting     9/2/2014
Dicerna Pharmaceuticals (DRNA) To Present At The Baird 2014 Health Care Conference     9/2/2014

Career Tips
Biotech Hiring Surge: Trends To Watch; Industry Tips From Arena Pharmaceuticals, Inc. (ARNA)     8/26/2014
Best Biotech Employers In America     8/26/2014
4 Untrue Things Biotech Employers May Tell Candidates     8/21/2014
Top 31 Common Interview Questions And Answers     8/21/2014
6 Tips To Ace Your Next Phone Interview     8/21/2014
How NOT To Write Your Resume     8/21/2014
Cover Letters For The Overqualified: How To Get Your Foot In The Door     8/21/2014
7 Reasons Why Recruiters And Employers Dread Reading A Resume     8/21/2014
Allergan Inc. (AGN) Layoffs: Employees Tell Their Side Of The Story     8/8/2014
Allergan Inc. (AGN) Layoffs Mean Resume-Tweaking Time: Tips For Creating An Exceptional Resume     8/7/2014
Top Exec Reveals 5 Habits That May Advance Your Career     8/7/2014
11 Hard To Believe Job Search Blunders     8/7/2014
How To Adopt A Recruiter's Mindset When Writing Your Resume     8/7/2014
Novartis AG (NVS) Layoffs: Game-Changing Tips For Today’s Job Seeker     8/7/2014
Half Of Biotech Employees Dissatisfied With Their Employer     7/24/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do

Press Release Submissions
Post your news